Allergan (AGN) Short Interest Ratio & Short Volume

Short interest is the volume of Allergan shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 15,010,000 shares of AGN short. Learn More on Allergan's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGN shares currently have a short interest ratio of 4.0. Learn More on Allergan's short interest ratio.

Allergan saw a increase in short interest in April. As of April 15th, there was short interest totaling 15,010,000 shares, an increase of 20.2% from the previous total of 12,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Allergan: Zoetis Inc. (0.80%), Bristol-Myers Squibb (1.73%), Royalty Pharma plc (3.27%), BeiGene, Ltd. (1.81%), Jazz Pharmaceuticals plc (5.41%), Apellis Pharmaceuticals, Inc. (8.66%), Glaukos Co. (6.95%), Bausch Health Companies Inc. (6.31%), Akero Therapeutics, Inc. (11.34%), Mirum Pharmaceuticals, Inc. (17.36%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($6.93 billion), Charter Communications, Inc. ($4.47 billion), Tesla, Inc. ($2.93 billion), Match Group, Inc. ($2.71 billion), The Charles Schwab Co. ($2.47 billion), Microchip Technology Incorporated ($2.38 billion), The Clorox Company ($2.03 billion), Aurora Cannabis Inc. ($1.85 billion), Wayfair Inc. ($1.84 billion), and PDD Holdings Inc. ($1.84 billion). View all of the most shorted stocks.

Short selling AGN is an investing strategy that aims to generate trading profit from Allergan as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Allergan occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AGN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGN, twice per month. The most recent reporting period available is April, 15 2020.